Afficher la fiche abrégée

dc.contributor.authorHomedes, Núriaen
dc.contributor.authorUgalde, Antonioen
dc.date.accessioned2012-06-26T01:49:01Z
dc.date.available2012-06-26T01:49:01Z
dc.date.created2005en
dc.date.issued2005en
dc.identifier.urihttps://apps.who.int/iris/handle/10665/72843
dc.descriptionSummaries in English, French, Spanish and Arabicen
dc.subject.meshDrugs, Genericen
dc.subject.meshTherapeutic Equivalencyen
dc.subject.meshDrug and Narcotic Controlen
dc.subject.meshLegislation, Drugen
dc.subject.meshLatin Americaen
dc.subject.meshArgentinaen
dc.subject.meshBrazilen
dc.subject.meshBoliviaen
dc.subject.meshChileen
dc.subject.meshColombiaen
dc.subject.meshCosta Ricaen
dc.subject.meshEcuadoren
dc.subject.meshNicaraguaen
dc.subject.meshUruguayen
dc.subject.otherPharmaceuticals and Biologicalsen
dc.titleMultisource drug policies in Latin America : survey of 10 countries / Núria Homedes and Antonio Ugaldeen
dc.title.alternativePolitiques en faveur des médicaments multisources en Amérique latine : enquête portant sur 10 pays : résuméen
dc.title.alternativePolíticas sobre medicamentos multiorigen en América Latina : encuesta de 10 países : Resumenen
dc.typeJournal / periodical articles
dc.subject.meshqualifierclassification legislationen
dc.relation.ispartofjournalBulletin of the World Health Organization : the International Journal of Public Health 2005 ; 83(‎1)‎ : 64-70


Fichier(‎s)‎ constituant ce document

Thumbnail

Ce document figure dans la(‎les)‎ collection(‎s)‎ suivante(‎s)‎

Afficher la fiche abrégée